Open access · CC-BY
via OpenAlex
Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats
Hongbo Wang, Hai Li, Yang Liu, Xiangdong Wang, Chengjian He, Jian Huang, Yijun Zhang, Yefa Yang, N N Ge
Hepatology Communications · 2026
Abstract
BACKGROUND: Obesity impairs liver regeneration by promoting chronic inflammation and metabolic dysfunction, especially in conditions like non-alcoholic fatty liver disease. Portal vein embolization (PVE), used to stimulate liver growth pre-hepatectomy, is less effective in obese subjects. Nicotinamide riboside (NR), a NAD+ precursor, improves mitochondrial function and lipid metabolism, but its role in liver regeneration under obese conditions remains unclear. Our study tried to investigate the effects and underlying mechanisms of NR on liver regeneration after PVE in high-fat diet (HFD)-induced obese rats. METHODS: HFD-fed rats underwent PVE and were treated with or without NR. Liver regeneration was assessed by histology, 5-ethynyl-2'-deoxyuridine (EdU) incorporation, immunohistochemistry, and liver function tests. NAD+ levels were quantified to confirm NR activity. Proteomics, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, Gene Ontology (GO) analysis, quantitative real-time PCR (qPCR), and western blotting were used to explore molecular mechanisms, focusing on the MCART1/ASB3 axis. RESULTS: Obesity impaired liver regeneration post-PVE, as evidenced by lipid accumulation, inflammation, reduced hepatocyte proliferation, and elevated liver enzymes. NR supplementation restored NAD+ levels, improved liver function, increased proliferative activity, and reduced steatosis. Mechanistically, NR upregulated MCART1 and ASB3 expression, promoting energy and lipid metabolism essential for regeneration. CONCLUSIONS: NR promotes liver regeneration after PVE in obese rats by enhancing NAD+-dependent metabolic pathways through the MCART1/ASB3 axis, offering a potential therapeutic strategy for obesity-associated liver dysfunction.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1097/hc9.0000000000000866
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Wang, H., Li, H., Liu, Y., Wang, X., He, C., Huang, J., Zhang, Y., Yang, Y., & Ge, N.N. (2026). Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats. <em>Hepatology Communications</em>. https://doi.org/10.1097/hc9.0000000000000866
Vancouver
Wang H, Li H, Liu Y, Wang X, He C, Huang J, et al. Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats. Hepatology Communications. 2026. doi:10.1097/hc9.0000000000000866.
BibTeX
@article{hongbo2026Nicoti,
title = {Nicotinamide riboside enhances liver regeneration via the MCART1/ASB3 axis in obesity-compromised rats},
author = {Hongbo Wang and Hai Li and Yang Liu and Xiangdong Wang and Chengjian He and Jian Huang and Yijun Zhang and Yefa Yang and N N Ge},
journal = {Hepatology Communications},
year = {2026},
doi = {10.1097/hc9.0000000000000866},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Human Genomics 2019
Open access · CC-BY
Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease
Catalysts 2023
Open access · CC-BY
Comprehensive Transformation of Escherichia coli for Nicotinamide Mononucleotide Production
Redox Biology 2018
Open access · CC-BY
Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway
Frontiers in sports and active living 2026
Open access · OA
The role of exercise in modulating NAD+ metabolic enzymes: mechanisms and health benefits.
JCI Insight 2021
Open access · CC-BY
SIRT3 is required for liver regeneration but not for the beneficial effect of nicotinamide riboside
Archives of Medical Research 2007
Citation only